In a recent study, researchers investigated the frequency of smoking, alcohol, and drug use, abuse, and dependence in patients with narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH) compared to controls. The study aimed to assess the vulnerability to substance abuse and addiction in NT1 patients and other hypersomniac patients. The results showed intriguing findings regarding addictive behaviors among patients with central hypersomnia, highlighting the importance of further research in understanding drug craving and relapse in these individuals (p. 573).
The study aimed to evaluate the frequencies of smoking, alcohol, and drug use, abuse, and dependence in different central hypersomnia disorders and controls. The research hypothesized that NT1 patients would show lower vulnerability to substance abuse and addiction compared to other hypersomniac patients and the general population. The cross-sectional study included 450 adult patients with NT1, NT2, IH, and 710 adult controls, assessing their alcohol consumption, smoking habits, and substance abuse and dependence diagnosis using standardized interviews (p. 573).
The study found an increased proportion of tobacco smokers in NT1 patients compared to controls and other hypersomniac patients, even after adjustments for confounders. NT1 patients also exhibited more regular alcohol consumption but lower rates of heavy drinking compared to controls. However, the frequency of illicit drug use, abuse, and dependence was low across all subgroups, with no significant differences between patients with central hypersomnia and controls. These results suggest that hypocretin deficiency may not be a protective factor against drug addiction in humans, contrary to findings in animal models (p. 573).